vs

Side-by-side financial comparison of HACKETT GROUP, INC. (HCKT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

HACKETT GROUP, INC. is the larger business by last-quarter revenue ($75.8M vs $57.6M, roughly 1.3× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -4.4%).

Hackett Limited is a British multi-channel retailer of clothing for men and boys, with a broad range of apparel and accessories. It was founded in 1983 in London, England. As of June 2019, the company had 160 stores globally, with its flagship store at 14 Savile Row in London. It is owned by both Lebanese holding company M1 Group and American L Capital Asia

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

HCKT vs PHAT — Head-to-Head

Bigger by revenue
HCKT
HCKT
1.3× larger
HCKT
$75.8M
$57.6M
PHAT
Growing faster (revenue YoY)
PHAT
PHAT
+98.5% gap
PHAT
94.1%
-4.4%
HCKT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCKT
HCKT
PHAT
PHAT
Revenue
$75.8M
$57.6M
Net Profit
$5.6M
Gross Margin
41.7%
86.7%
Operating Margin
12.0%
Net Margin
7.4%
Revenue YoY
-4.4%
94.1%
Net Profit YoY
56.9%
71.6%
EPS (diluted)
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCKT
HCKT
PHAT
PHAT
Q4 25
$75.8M
$57.6M
Q3 25
$73.1M
$49.5M
Q2 25
$78.9M
$39.5M
Q1 25
$77.9M
$28.5M
Q4 24
$79.2M
$29.7M
Q3 24
$79.8M
$16.4M
Q2 24
$77.7M
$7.3M
Q1 24
$77.2M
Net Profit
HCKT
HCKT
PHAT
PHAT
Q4 25
$5.6M
Q3 25
$2.5M
$-30.0M
Q2 25
$1.7M
$-75.8M
Q1 25
$3.1M
$-94.3M
Q4 24
$3.6M
Q3 24
$8.6M
$-85.6M
Q2 24
$8.7M
$-91.4M
Q1 24
$8.7M
Gross Margin
HCKT
HCKT
PHAT
PHAT
Q4 25
41.7%
86.7%
Q3 25
40.7%
87.5%
Q2 25
35.4%
87.2%
Q1 25
35.8%
86.9%
Q4 24
39.4%
87.1%
Q3 24
29.2%
85.6%
Q2 24
27.5%
81.2%
Q1 24
26.2%
Operating Margin
HCKT
HCKT
PHAT
PHAT
Q4 25
12.0%
Q3 25
7.5%
-30.8%
Q2 25
5.8%
-151.7%
Q1 25
5.7%
-276.5%
Q4 24
9.8%
Q3 24
16.0%
-433.0%
Q2 24
16.1%
-1055.4%
Q1 24
14.9%
Net Margin
HCKT
HCKT
PHAT
PHAT
Q4 25
7.4%
Q3 25
3.5%
-60.5%
Q2 25
2.1%
-191.9%
Q1 25
4.0%
-330.7%
Q4 24
4.5%
Q3 24
10.8%
-523.3%
Q2 24
11.3%
-1248.6%
Q1 24
11.3%
EPS (diluted)
HCKT
HCKT
PHAT
PHAT
Q4 25
$0.20
Q3 25
$0.09
$-0.41
Q2 25
$0.06
$-1.05
Q1 25
$0.11
$-1.31
Q4 24
$0.11
Q3 24
$0.31
$-1.32
Q2 24
$0.31
$-1.56
Q1 24
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCKT
HCKT
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$18.2M
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$68.1M
$-438.2M
Total Assets
$206.4M
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCKT
HCKT
PHAT
PHAT
Q4 25
$18.2M
$130.0M
Q3 25
$13.9M
$135.2M
Q2 25
$10.1M
$149.6M
Q1 25
$9.2M
$212.3M
Q4 24
$16.4M
$297.3M
Q3 24
$10.0M
$334.7M
Q2 24
$19.1M
$276.2M
Q1 24
$13.0M
Total Debt
HCKT
HCKT
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
HCKT
HCKT
PHAT
PHAT
Q4 25
$68.1M
$-438.2M
Q3 25
$101.6M
$-422.5M
Q2 25
$119.8M
$-405.8M
Q1 25
$114.4M
$-338.4M
Q4 24
$115.6M
$-253.6M
Q3 24
$110.9M
$-187.1M
Q2 24
$102.2M
$-233.8M
Q1 24
$93.5M
Total Assets
HCKT
HCKT
PHAT
PHAT
Q4 25
$206.4M
$259.1M
Q3 25
$200.7M
$240.3M
Q2 25
$200.5M
$250.2M
Q1 25
$191.8M
$294.2M
Q4 24
$193.3M
$378.3M
Q3 24
$190.8M
$387.0M
Q2 24
$187.5M
$319.4M
Q1 24
$179.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCKT
HCKT
PHAT
PHAT
Operating Cash FlowLast quarter
$19.1M
$-166.8M
Free Cash FlowOCF − Capex
$-167.0M
FCF MarginFCF / Revenue
-290.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
3.41×
TTM Free Cash FlowTrailing 4 quarters
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCKT
HCKT
PHAT
PHAT
Q4 25
$19.1M
$-166.8M
Q3 25
$11.4M
$-14.1M
Q2 25
$5.6M
$-62.7M
Q1 25
$4.2M
$-84.9M
Q4 24
$20.6M
$-266.8M
Q3 24
$10.6M
$-63.6M
Q2 24
$13.7M
$-70.7M
Q1 24
$2.8M
Free Cash Flow
HCKT
HCKT
PHAT
PHAT
Q4 25
$-167.0M
Q3 25
$-14.1M
Q2 25
$3.7M
$-62.8M
Q1 25
$2.6M
$-84.9M
Q4 24
$19.6M
$-266.9M
Q3 24
$9.3M
$-63.6M
Q2 24
$12.8M
$-70.8M
Q1 24
$1.8M
FCF Margin
HCKT
HCKT
PHAT
PHAT
Q4 25
-290.0%
Q3 25
-28.6%
Q2 25
4.7%
-159.0%
Q1 25
3.4%
-297.9%
Q4 24
24.8%
-899.8%
Q3 24
11.7%
-389.0%
Q2 24
16.5%
-966.2%
Q1 24
2.4%
Capex Intensity
HCKT
HCKT
PHAT
PHAT
Q4 25
0.4%
Q3 25
0.1%
Q2 25
2.4%
0.2%
Q1 25
2.0%
0.1%
Q4 24
1.3%
0.5%
Q3 24
1.5%
0.3%
Q2 24
1.1%
0.6%
Q1 24
1.2%
Cash Conversion
HCKT
HCKT
PHAT
PHAT
Q4 25
3.41×
Q3 25
4.47×
Q2 25
3.40×
Q1 25
1.33×
Q4 24
5.79×
Q3 24
1.23×
Q2 24
1.57×
Q1 24
0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCKT
HCKT

Global S And BT$39.1M52%
Sap Solutions$22.4M30%
Consulting And Software Support And Maintenance$14.3M19%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons